Search Results 81-90 of 25237 for liver disease
A population-based, longitudinal study compares the trajectory of nonalcoholic fatty liver disease (NAFLD) in lean, overweight and obese individuals.
This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic response (SVR) after ...
Acute liver failure. Displaying 10 studies. Bleeding in Hospitalized Patients with Liver Disease Rochester, MN; Jacksonville, FL. The ...
Approach to the patient with abnormal liver and biochemical function tests. ... Liver in systemic disease. In: MacSween's Pathology of the Liver, 8th ed ...
Uncovering the genetic basis for liver disease. Dr. Wangensteen's lab uses cutting-edge molecular genetics tools and genomics analysis of patient genetic ...
Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common ...
This technology enables them to study important aspects of primary sclerosing cholangitis, a rare bile duct disease that often destroys the liver. Using these ...
Research in Dr. Hirsova's Liver Disease Immunobiology Lab at Mayo Clinic is focused on nonalcoholic steatohepatitis (NASH).
Mayo Clinic researchers are exploring several new treatment options for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
About this study. A variety of liver insults lead to pathological changes in liver architecture that culminate in cirrhosis. While invasive liver biopsy was ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.